KRT5 and digestive system neoplasm: This panel can include antibodies against antigens commonly expressed by genitourinary or gastrointestinal tumors, such as cytokeratins (CKAE1/AE3, CK7, CK20, CK5/6), p63 (Tumor protein 63), PSA (prostatic specific antigen) or CDX2.